Soleus Capital Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-789,060
Closed -$23.4M 106
2025
Q2
$23.4M Hold
789,060
1.55% 21
2025
Q1
$24.1M Buy
789,060
+395,000
+100% +$13.3M 1.73% 17
2024
Q4
$15.6M Sell
394,060
-243,638
-38% -$9.48M 0.98% 32
2024
Q3
$24.7M Sell
637,698
-144,079
-18% -$5.83M 1.91% 17
2024
Q2
$32.9M Sell
781,777
-19,043
-2% -$650K 2.9% 8
2024
Q1
$23.5M Buy
800,820
+29,120
+4% +$929K 1.74% 14
2023
Q4
$28.1M Sell
771,700
-459,162
-37% -$15M 3.11% 11
2023
Q3
$39.5M Sell
1,230,862
-105,976
-8% -$3.6M 3.64% 5
2023
Q2
$41.9M Buy
1,336,838
+444,160
+50% +$10.1M 4.65% 4
2023
Q1
$20.3M Buy
892,678
+117,367
+15% +$3.02M 2.11% 12
2022
Q4
$26.5M Buy
775,311
+6,833
+0.9% +$229K 3.8% 6
2022
Q3
$23.4M Buy
768,478
+107,474
+16% +$3.69M 3.17% 10
2022
Q2
$24.6M Buy
661,004
+102,564
+18% +$3.98M 3.84% 4
2022
Q1
$25.3M Buy
558,440
+25,683
+5% +$1.12M 3.27% 4
2021
Q4
$25.7M Buy
532,757
+151,235
+40% +$7.62M 2.57% 8
2021
Q3
$21.2M Buy
381,522
+103,118
+37% +$5.73M 3.31% 8
2021
Q2
$15.1M Buy
278,404
+124,129
+80% +$6.81M 2.32% 13
2021
Q1
$8.65M Buy
154,275
+61,300
+66% +$3.06M 1.56% 13
2020
Q4
$4.05M Buy
92,975
+15,692
+20% +$618K 0.53% 24
2020
Q3
$3.01M Buy
77,283
+33,305
+76% +$1.46M 1.59% 26
2020
Q2
$1.9M Buy
+43,978
New +$1.66M 1.08% 30

Other funds holding SRDX

Soleus Capital Management's SRDX Position: Q3 2025 in Review

Soleus Capital Management sold out of Surmodics (SRDX) in Q3 2025, closing a stake of 789,060 shares — an estimated $23.4M sold.

Soleus Capital Management first reported a position in SRDX in Q2 2020 and held it in 21 quarters. The position peaked at $41.9M in Q2 2023. 146 funds tracked by Wall St. Rank hold SRDX as of Q3 2025.

  • Soleus Capital Management reported no remaining Surmodics position as of Q3 2025 after selling out during the quarter.
  • Soleus Capital Management sold 789,060 Surmodics shares in Q3 2025, an estimated $23.4M.
  • Soleus Capital Management first reported a position in Surmodics in Q2 2020 and held it in 21 quarters.
  • Soleus Capital Management's Surmodics position peaked at $41.9M in Q2 2023.
  • 146 funds tracked by Wall St. Rank held Surmodics as of Q3 2025.

Based on Soleus Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.